Drawing on statistical data, this chapter illustrates the considerable variations in the backgrounds of healthy volunteers. I present the demographic profiles of healthy volunteers and introduce the relationship between income, financial rewards, and financial security. I illustrate how healthy volunteering in the UK may not be delineated purely as the preserve of marginalised and unemployed individuals. Rather, based on the sample used in the research informing this book, it appears that healthy volunteers in the UK are mostly employed in full-time and relatively well-paid jobs. I argue that healthy volunteer involvement should be seen in the context of rising costs of living and that this makes taking part in clinical drug trials a worthw...
In March 2006, six men who were taking part in testing a new drug, known as ‘TGN1412’, suffered mult...
Volunteering is remarkably widespread in almost all the European countries and the number of people ...
The main goal of early phase trials is to gain knowledge about the clinical suitability of novel com...
Contemporary society’s, especially the West, has seen an increase in the production and use of pharm...
While the previous two chapters question the idea of autonomy in healthy volunteering, here I interr...
This book provides a richly detailed contribution to the understanding of healthy volunteer experien...
This chapter introduces the rationale, context, and main themes of the book. It explores what clinic...
Other than the financial motivations for enrolling in Phase I trials, research on how healthy volunt...
Recent sociological research has raised important sociological and ethical questions about the role ...
In this concluding chapter‚ I present the overall argument of this book. My discussion in this book ...
1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacolo...
Recruitment of adequate number of healthy volunteers is vital for success of clinical trials but the...
Having critiqued voluntarism and altruism to situate healthy volunteering as an economic exchange an...
Phase I testing of investigational drugs relies on healthy volunteers as research participants. Many...
Study goal: This study was carried out to answer the following research question: which motivation d...
In March 2006, six men who were taking part in testing a new drug, known as ‘TGN1412’, suffered mult...
Volunteering is remarkably widespread in almost all the European countries and the number of people ...
The main goal of early phase trials is to gain knowledge about the clinical suitability of novel com...
Contemporary society’s, especially the West, has seen an increase in the production and use of pharm...
While the previous two chapters question the idea of autonomy in healthy volunteering, here I interr...
This book provides a richly detailed contribution to the understanding of healthy volunteer experien...
This chapter introduces the rationale, context, and main themes of the book. It explores what clinic...
Other than the financial motivations for enrolling in Phase I trials, research on how healthy volunt...
Recent sociological research has raised important sociological and ethical questions about the role ...
In this concluding chapter‚ I present the overall argument of this book. My discussion in this book ...
1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacolo...
Recruitment of adequate number of healthy volunteers is vital for success of clinical trials but the...
Having critiqued voluntarism and altruism to situate healthy volunteering as an economic exchange an...
Phase I testing of investigational drugs relies on healthy volunteers as research participants. Many...
Study goal: This study was carried out to answer the following research question: which motivation d...
In March 2006, six men who were taking part in testing a new drug, known as ‘TGN1412’, suffered mult...
Volunteering is remarkably widespread in almost all the European countries and the number of people ...
The main goal of early phase trials is to gain knowledge about the clinical suitability of novel com...